• About
    • General information
    • Mission and values
    • History
    • Management
    • Cooperation
  • Production
    • Quality Management System
    • Production capacities
    • Manufacturing capabilities
  • Innovation
    • Avexima R&D Center
    • Departments
    • Technological Equipment
    • Analytical Equipment
  • Medicines
  • Press center
    • News
    • Press kit
  • Career
    • career
  • Contacts
  • +7 495 258-45-28
  • INFO@AVEXIMA.RU
back
  • News
  • Press kit

CARING FOR HEALTH - CREATING THE FUTURE!

News

Alfiya Gabidova, Deputy general director for Development and Science at JSC Avexima, moderated a session titled «Russky ISTC: From Ocean Bio-Raw Materials to Pharmaceutical Substances for the World» at the 10th Eastern Economic Forum.

6 September 2025

Alfiya Gabidova, Deputy general director for Development and Science at JSC Avexima, moderated a session titled «Russky ISTC: From Ocean Bio-Raw Materials to Pharmaceutical Substances for the World» at the 10th Eastern Economic Forum.

JSC Avexima, Far Eastern Federal University, and Russky ISTC Development Fund sign Cooperation agreement

4 September 2025

JSC Avexima, Far Eastern Federal University, and Russky ISTC Development Fund sign Cooperation agreement

JSC Avexima presents on IP Strategy at the 6th International «Intellectual Property for the Future» Forum

23 April 2025

JSC Avexima presents on IP Strategy at the 6th International «Intellectual Property for the Future» Forum

Pharmaceutical community recognizes Avexima drug: Devilam wins 3rd place in «Drug of the Year» сategory at «Platinum Ounce» Awards

10 April 2025

Pharmaceutical community recognizes Avexima drug: Devilam wins 3rd place in «Drug of the Year» сategory at «Platinum Ounce» Awards

Professional development and experience: JSC Avexima participated in an educational project in gynecology

4 April 2025

Professional development and experience: JSC Avexima participated in an educational project in gynecology

New Export Opportunities: JSC Avexima joins business mission to South Africa

7 March 2025

New Export Opportunities: JSC Avexima joins business mission to South Africa

  • 1
  • 2
  • 3
  • 4
  • 5

Shown 18 from 68 news

Press kit

Logos

Avexima logo Avexima logo (png 45.11 Kb)

Documents

Company information Company information (pdf 237.54 Kb)

© 2011—2026 JSC Avexima.
All rights of the website are reserved

Personal Data Processing Policy

Avexima invites pharmaceutical distributors and pharmacy chains to cooperate. We will be happy to answer all your questions by phone or e-mail:

  • +7 495 258-45-28
  • INFO@AVEXIMA.RU
  • LENINGRADSKY PR., BLD. 1, MOSCOW, 125284

Applicant's profile

Desired Area *

Attach your resume
Maximum file size 5 MB

Provide information on the safety of the drug (for the patient)

1000

stage 1/5

Report
an undesirable reaction

Sender Information

Patient Information

Information about the suspected drug

Description of the event related to the safety and efficacy of the drug

Additional information

Gestation period in weeks
years
  • years
  • month
  • days
Characters left: 300
Characters left: 300
Characters left: 300
Characters left: 300
Characters left: 1000
Characters left: 300
Characters left: 300
Characters left: 300

Criteria for the severity of an adverse reaction

Outcome

Characters left: 1000
Characters left: 500

Attach files (for example, test results, discharge, doctor's report, etc.) Files should not be larger than 5 MB

Medical Information Request Form

You

Preferred way to receive a response

Leave a request about the quality of the drug

The person reporting a problem with the quality of the medicinal product
Information about the medicinal product and the essence of the treatment

Photos showing a problem with the quality of the drug, including photos with the batch number of the drug

The website uses cookies to personalize user services. By continuing to use the website, you agree to the Cookie Policy and consent to the processing of personal data by Avexima OJSC (31a Leningradsky Ave., building 1, 125284, Moscow). You can disable the storage of cookies in your browser settings.

accept and close